Terms: = Leukemia AND PICALM, CLTH, 8301, ENSG00000073921, CALM, Q13492
111 results:
1. Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies.
Ip BBK; Wong ATC; Law JHY; Au CH; Ma SY; Chim JCS; Liang RHS; Leung AYH; Wan TSK; Ma ESK
Sci Rep; 2024 Mar; 14(1):6400. PubMed ID: 38493200
[TBL] [Abstract] [Full Text] [Related]
2. Genomic and global gene expression profiling in pediatric and young adult acute leukemia with picalm::MLLT10 Fusion.
Ma J; Liu YC; Voss RK; Ma J; Palagani A; Caldwell E; Rosikiewicz W; Cardenas M; Foy S; Umeda M; Wilkinson MR; Inaba H; Klco JM; Rubnitz JE; Wang L
Leukemia; 2024 May; 38(5):981-990. PubMed ID: 38429501
[TBL] [Abstract] [Full Text] [Related]
3. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
[TBL] [Abstract] [Full Text] [Related]
4. Genetic Characterization of Pediatric Mixed Phenotype Acute leukemia (MPAL).
Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S
Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288
[TBL] [Abstract] [Full Text] [Related]
5. Treatment outcomes of childhood picalm::MLLT10 acute leukaemias.
Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
[TBL] [Abstract] [Full Text] [Related]
6. An unusual presentation of a pediatric patient with mixed phenotypic acute leukemia with
Smith E; Krishnan C
Pediatr Hematol Oncol; 2023; 40(8):778-785. PubMed ID: 37171905
[TBL] [Abstract] [Full Text] [Related]
7. MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins.
Komata Y; Kanai A; Maeda T; Inaba T; Yokoyama A
Nat Commun; 2023 Apr; 14(1):1979. PubMed ID: 37031220
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic leukemia.
Dupouy S; Marchiq I; Derippe T; Almena-Carrasco M; Jozwik A; Fouliard S; Adimy Y; Geronimi J; Graham C; Jain N; Maus MV; Mohty M; Boissel N; Teshima T; Kato K; Benjamin R; Balandraud S
Cancer Res Commun; 2022 Nov; 2(11):1520-1531. PubMed ID: 36970059
[TBL] [Abstract] [Full Text] [Related]
9. RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification.
Yang Y; Shu Y; Tang Y; Zhao S; Jia Y; Ji J; Ma H; Lin T; Zheng K; Xu H; Wu Y
Cancer Med; 2023 Apr; 12(8):9156-9166. PubMed ID: 36916780
[TBL] [Abstract] [Full Text] [Related]
10. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (calm): a phase 1, dose-escalation trial.
Benjamin R; Jain N; Maus MV; Boissel N; Graham C; Jozwik A; Yallop D; Konopleva M; Frigault MJ; Teshima T; Kato K; Boucaud F; Balandraud S; Gianella-Borradori A; Binlich F; Marchiq I; Dupouy S; Almena-Carrasco M; Pannaux M; Fouliard S; Brissot E; Mohty M;
Lancet Haematol; 2022 Nov; 9(11):e833-e843. PubMed ID: 36228643
[TBL] [Abstract] [Full Text] [Related]
11. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.
Steimlé T; Dourthe ME; Alcantara M; Touzart A; Simonin M; Mondesir J; Lhermitte L; Bond J; Graux C; Grardel N; Cayuela JM; Arnoux I; Gandemer V; Balsat M; Vey N; Macintyre E; Ifrah N; Dombret H; Petit A; Baruchel A; Ruminy P; Boissel N; Asnafi V
Blood Cancer J; 2022 Jan; 12(1):14. PubMed ID: 35082269
[TBL] [Abstract] [Full Text] [Related]
12. [Lineage switch from T-lymphoblastic leukemia to myeloid leukemia at relapse].
Kuze A; Ida N; Hosono N; Negoro E; Yamauchi T
Rinsho Ketsueki; 2021; 62(7):721-726. PubMed ID: 34349054
[TBL] [Abstract] [Full Text] [Related]
13. The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
Klein BJ; Deshpande A; Cox KL; Xuan F; Zandian M; Barbosa K; Khanal S; Tong Q; Zhang Y; Zhang P; Sinha A; Bohlander SK; Shi X; Wen H; Poirier MG; Deshpande AJ; Kutateladze TG
Nat Commun; 2021 Jul; 12(1):4130. PubMed ID: 34226546
[TBL] [Abstract] [Full Text] [Related]
14. calm supports clathrin-coated vesicle completion upon membrane tension increase.
Willy NM; Colombo F; Huber S; Smith AC; Norton EG; Kural C; Cocucci E
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34155137
[TBL] [Abstract] [Full Text] [Related]
15. A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML.
Chen BR; Deshpande A; Barbosa K; Kleppe M; Lei X; Yeddula N; Vela PS; Campos AR; Wechsler-Reya RJ; Bagchi A; Meshinchi S; Eaves C; Jeremias I; Haferlach T; Frank DA; Ronai Z; Chanda S; Armstrong SA; Adams PD; Levine RL; Deshpande AJ
Blood; 2021 Jun; 137(24):3403-3415. PubMed ID: 33690798
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic leukemia in Canada.
Lachaine J; Beauchemin C; Guinan K; Thebault P; Aw A; Banerji V; Fleury I; Owen C
Curr Oncol; 2021 Jan; 28(1):332-345. PubMed ID: 33435341
[No Abstract] [Full Text] [Related]
17. Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V.
Rai S; Tanaka H; Suzuki M; Espinoza JL; Kumode T; Tanimura A; Yokota T; Oritani K; Watanabe T; Kanakura Y; Matsumura I
Nat Commun; 2020 Aug; 11(1):4147. PubMed ID: 32811837
[TBL] [Abstract] [Full Text] [Related]
18. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring picalm-MLLT10 fusion with aberrant expression of B-cell antigens.
Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
[TBL] [Abstract] [Full Text] [Related]
19. Acute myeloid leukemia driven by the calm-AF10 fusion gene is dependent on BMI1.
Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
[TBL] [Abstract] [Full Text] [Related]
20. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.
López-Nieva P; Fernández-Navarro P; Graña-Castro O; Andrés-León E; Santos J; Villa-Morales M; Cobos-Fernández MÁ; González-Sánchez L; Malumbres M; Salazar-Roa M; Fernández-Piqueras J
Sci Rep; 2019 Mar; 9(1):5179. PubMed ID: 30914738
[TBL] [Abstract] [Full Text] [Related]
[Next]
